HMB is one of the most common symptoms requiring investigation and treatment. The NICE HMB Guideline first produced in 2007 has been substantially revised in line with recent innovations and the accumulated evidence.
The updated NICE guideline was published in February 2018 and impacts on clinical practice in both primary and secondary care.
Some of the new recommendations have been considered controversial.
The BSGE has put together this meeting to cover the contemporary management of HMB and its implementation within the context of the new NICE guideline.
The meeting includes a range of speakers: Some who contributed to the guideline, some who criticised it and others who have provided major contributions to the scientific literature in HMB.
Who should attend?
Gynaecology Consultants and trainees
Nurses in primary care and hospitals who are involved in the care of women with HMB
Date and Venue:
Friday, 7th December 2018
Nuffield Hall, Royal College of Obstetricians and Gynaecologists,
27 Sussex Place Regent’s Park, London, NW1 4RG, UK
Directions to the RCOG can be viewed here.
You can download provisional programme here.
Sponsorship opportunities letter for exhibitors can be downloaded here.
BSGE wishes to express its sincere gratitude and appreciation to sponsors of this meeting and for their continuing support of the society.
Kebomed offers innovative, tailored and cost effective solutions, which reflect the needs of the local healthcare system. We provide tailored solutions to medical device manufacturers wishing to develop and grow their business, providing one contact across all of Europe.We strive to be the preferred point of contact and the first choice of both our customers and our suppliers for medical products across Europe.
Hologic, Inc. is a leading developer, manufacturer and supplier of premium diagnostic and medical imaging systems and surgical products dedicated to serving the healthcare needs of women. Hologic leads the industry in digital mammography systems and offers the most advanced technology for breast imaging and intervention.
Hologic is committed to enhancing women’s lives through earlier detection, improved diagnosis and less invasive treatments. Core business units are focused on mammography and breast biopsy, radiation treatment for early-stage breast cancer, cervical cancer screening, treatment for menorrhagia, polyps and fibroids, osteoporosis assessment, preterm birth screening, and mini C-arm and extremity MRI imaging for orthopedic applications.